Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Annual Report 2023 - Revised Edition Summary.
Aug 7 12:00 ET
Heilongjiang ZBD Pharmaceutical Co., Ltd. 2023 Semi-Annual Report - Revised Edition Summary.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Q1/2024 Revised Report
Heilongjiang ZBD Pharmaceutical Co., Ltd. Annual Report 2023 - Revised Edition.
Read more
Updated: Aug 19, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data